RISING health care costs could lead to tighter government price controls, a Fitch Group unit said, creating headwinds for pharmaceutical companies and speeding up a shift toward cheaper generics. “The ...

Sales of weight loss medicines like Ozempic and Mounjaro have skyrocketed in South Africa in recent years. However, they remain too expensive for most people who might benefit from the jabs. Spotlight ...

Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s blockbuster weight-loss drug ‌Wegovy at a competitive price that could be up to 60% lower than the branded ...

In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal Court ruling that blocks local generics maker ...

After a decade of Lupin recovering in the corporate equivalent of an ICU, DBG (Desh Bandhu Gupta) did not mistake the consolation of having avoided disaster for good fortune. The decade since 1993 had ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Lupin Ltd. posted a 37.4 per cent year-on-year (YoY) jump in quarterly net profit to Rs. 1,180.5 crore in Q3 FY26, driven primarily by record US sales, stronger gross margins, and a favourable product ...

The EU-India trade deal is set to open Europe up to more Indian medicines, deepening reliance on one of its biggest foreign suppliers when the bloc is trying to bolster its own drug production to ...

From flour to salad dressing, find out which name-brand products our editors swear by when shopping. Reviewed by Dietitian Mandy Enright, M.S., RDN, RYT Sometimes name-brand foods are superior to ...

Jennifer Christian-Herman ( [email protected]) is associate director, Health Services Research, at Cerner Health Insights in Beverly Hills, California. Matthew Emons is a principal investigator there, ...